Abbonarsi

Financial burden, distress, and toxicity in cardiovascular disease - 19/06/21

Doi : 10.1016/j.ahj.2021.04.011 
Samuel D. Slavin, MD a, b, Rohan Khera, MD, MSCS c, S. Yousuf Zafar, MD d, e, f, g, Khurram Nasir, MD, MPH h, i, Haider J. Warraich, MD a, b, j,
a Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA 
b Harvard Medical School, Boston, MA 
c Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT 
d Duke University School of Medicine, Durham, NC 
e Duke Margolis Center for Health Policy, Durham, NC 
f Sanford School of Public Policy, Duke University, Durham, NC 
g Duke Cancer Institute, Durham, NC 
h Division of Cardiovascular Prevention and Wellness, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX 
i Center for Outcomes Research, Houston Methodist, Houston, TX 
j Department of Medicine, Cardiology Section, VA Boston Healthcare System, Boston, MA 

Reprint requests: Haider J. Warraich, 4B-132, VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA 021324B-132, VA Boston Healthcare System1400 VFW ParkwayWest RoxburyMA02132

Highlights

Cardiovascular disease (CVD) is a major source of financial burden and financial distress, which can cause psychological distress, cost-related care non-adherence or care deferral, and create tradeoffs with basic needs.
To reduce financial distress, policymakers can expand insurance coverage, health systems can limit expenditure on low-benefit, high-cost treatments, physicians can engage in shared-decision-making for high-cost interventions, and community-based initiatives can support patients with system navigation and financial coping.
Avenues for research include analysis of how healthcare policies affect financial burden, comparative effectiveness studies examining high and low-cost strategies for CVD management and testing interventions to reduce financial burden.

Il testo completo di questo articolo è disponibile in PDF.

Riassunto

Cardiovascular disease (CVD) is a major source of financial burden and distress, which has 3 main domains: (1) psychological distress; (2) cost-related care non-adherence or medical care deferral, and (3) tradeoffs with basic non-medical needs. We propose 4 ways to reduce financial distress in CVD: (1) policymakers can expand insurance coverage and curtail underinsurance; (2) health systems can limit expenditure on low-benefit, high-cost treatments while developing services for high-risk individuals; (3) physicians can engage in shared-decision-making for high-cost interventions, and (4) community-based initiatives can support patients with system navigation and financial coping. Avenues for research include (1) analysis of how healthcare policies affect financial burden; (2) comparative effectiveness studies examining high and low-cost strategies for CVD management; and (3) studying interventions to reduce financial burden, financial coaching, and community health worker integration.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2021  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 238

P. 75-84 - Agosto 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial
  • Xiulin Shi, Jiang He, Mingzhu Lin, Changqin Liu, Bing Yan, Haiqu Song, Caihong Wang, Fangsen Xiao, Peiying Huang, Liying Wang, Zhibin Li, Yinxiang Huang, Mulin Zhang, Chung-Shiuan Chen, Katherine Obst, Weihua Li, Shuyu Yang, Guanhua Yao, Xuejun Li
| Articolo seguente Articolo seguente
  • Cangrelor vs. glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention
  • Charan Yerasi, Brian C. Case, Chava Chezar-Azerrad, Brian J. Forrestal, Giorgio A. Medranda, Corey Shea, Cheng Zhang, Itsik Ben-Dor, Lowell F. Satler, Nelson L. Bernardo, Hayder Hashim, Hector M. Garcia-Garcia, Ron Waksman

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.